LGT Fund Management’s ResMed RMD Stock Holding History

LGT Fund Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-910	Closed	-$246K	–	246
2025 Q3	$246K	Sell	910 -220	-19%	-$60.1K	0.02%	224
2025 Q2	$292K	Sell	1,130 -120	-10%	-$28.6K	0.03%	211
2025 Q1	$280K	Sell	1,250 -270	-18%	-$63K	0.03%	211
2024 Q4	$348K	Hold	1,520	–	–	0.03%	214
2024 Q3	$363K	Buy	+1,520	New	+$340K	0.04%	175
2023 Q2	–	Sell	-1,247	Closed	-$273K	–	144
2023 Q1	$273K	Hold	1,247	–	–	0.12%	114
2022 Q4	$260K	Hold	1,247	–	–	0.11%	108
2022 Q3	$272K	Hold	1,247	–	–	0.13%	101
2022 Q2	$261K	Hold	1,247	–	–	0.04%	163
2022 Q1	$307K	Hold	1,247	–	–	0.04%	166
2021 Q4	$325K	Buy	+1,247	New	+$324K	0.09%	132

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

LGT Fund Management's RMD Position: Q4 2025 in Review

LGT Fund Management sold out of ResMed (RMD) in Q4 2025, closing a stake of 910 shares — an estimated $246K sold.

LGT Fund Management first reported a position in RMD in Q4 2021 and held it in 11 quarters. The position peaked at $363K in Q3 2024. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

LGT Fund Management reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
LGT Fund Management sold 910 ResMed shares in Q4 2025, an estimated $246K.
LGT Fund Management first reported a position in ResMed in Q4 2021 and held it in 11 quarters.
LGT Fund Management's ResMed position peaked at $363K in Q3 2024.
948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on LGT Fund Management's 13F filing for Q4 2025, filed 5 Feb 2026.